In his new article in The Journal of Comparative Law, Director Timothy McKenna employs the Kangmei Pharmaceutical Co., Ltd fraud incident as a case study to compare per-share damages assessed using the Intermediate People’s Court of Guangzhou’s methodology and the typical methodology for securities litigation in the US. The article, “Damages Per Share in Securities Litigation: A Comparison of Chinese and US Systems,” observes the Intermediate People’s Court of Guangzhou’s method is not centered on what can be directly observed about the impact of the fraud. Mr. McKenna points out flaws in the design and suggests adjustments to follow the US method for the calculation of economic damages.